eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Frequently asked questions
What sector does eXoZymes, Inc. (EXOZ) operate in?
eXoZymes, Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is eXoZymes, Inc. (EXOZ) current stock price?
As of the latest data, eXoZymes, Inc. stock price is $3.79, with a previous close of $3.75. eXoZymes, Inc. gained $0.04 in the last trading session, representing a 1.07% increase.
What is eXoZymes, Inc. (EXOZ) current market capitalization?
eXoZymes, Inc. market cap is approximately 35.26 million.
What is eXoZymes, Inc. (EXOZ) Earnings Per Share (EPS)?
The trailing EPS is -$1.20.
What is eXoZymes, Inc. (EXOZ) EBITDA?
eXoZymes, Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.03 million.
Does eXoZymes, Inc. (EXOZ) pay dividends?
No. eXoZymes, Inc. does not pay a dividend.
When is eXoZymes, Inc. (EXOZ) next earnings report?
eXoZymes, Inc. is expected to release its next earnings report on September 30, 2026.
What is eXoZymes, Inc. (EXOZ) beta (volatility) score?
eXoZymes, Inc. has a beta of 0.736, indicating lower volatility than the overall market.